Rosalind Advisors, Inc.
CIK 1622627 · Holdings on Dec 31, 2023 · First reported Feb 14, 2024
Top ten holdings
Q4 2023- LYRA8.28%
- MYO8.05%
- CATB7.25%
- XERS6.97%
- VRDN6.57%
- CMPS5.85%
- OPTN5.27%
- MDWD5.16%
- MDGL4.84%
- CLRB4.65%
Share classes counted separately62.89%
Portfolio value by quarter
Top 10 holdings 27
USD · B = billion · M = million; expand a row for exact values| # | Security | Value | Weight | Quantity | Weight / quantity change | Activity | |
|---|---|---|---|---|---|---|---|
| 01 | LYRALYRA THERAPEUTICS INC View history and evidence | $9.90M | 8.28% | 1.89M shares | Prior unavailable — | — | ↗▾ |
| 02 | MYOMYOMO INCCOM NEW View history and evidence | $9.62M | 8.05% | 1.92M shares | Prior unavailable — | — | ↗▾ |
| 03 | CATBASTRIA THERAPEUTICS INC View history and evidence | $8.67M | 7.25% | 1.13M shares | Prior unavailable — | — | ↗▾ |
| 04 | XERSXERIS BIOPHARMA HOLDINGS INC View history and evidence | $8.33M | 6.97% | 3.54M shares | Prior unavailable — | — | ↗▾ |
| 05 | VRDNVIRIDIAN THERAPEUTICS INC View history and evidence | $7.85M | 6.57% | 360.33K shares | Prior unavailable — | — | ↗▾ |
| 06 | CMPSCOMPASS PATHWAYS PLCSPONSORED ADS View history and evidence | $6.99M | 5.85% | 798.50K shares | Prior unavailable — | — | ↗▾ |
| 07 | OPTNOPTINOSE INC View history and evidence | $6.30M | 5.27% | 4.89M shares | Prior unavailable — | — | ↗▾ |
| 08 | MDWDMEDIWOUND LTDSHS NEW View history and evidence | $6.17M | 5.16% | 606.75K shares | Prior unavailable — | — | ↗▾ |
| 09 | MDGLMADRIGAL PHARMACEUTICALS INC View history and evidence | $5.78M | 4.84% | 25.00K shares | Prior unavailable — | — | ↗▾ |
| 10 | CLRBCELLECTAR BIOSCIENCES INCCOM NEW View history and evidence | $5.56M | 4.65% | 2.01M shares | Prior unavailable — | — | ↗▾ |
Options overlay 3
$1.90M notionalPut and Call positions are separate. Notional is based on underlying securities, not option premium, market value or net exposure. Quantities are underlying shares.
| Security | Put / Call | Underlying shares | Notional | Quantity change | |
|---|---|---|---|---|---|
SRPTSAREPTA THERAPEUTICS INCPUT View history and evidence | Put | 57.40K | $832.30K | — | ▾ |
QQQ 06.16.28 P590June 28 Puts on QQQ USUNIT SER 1 View history and evidence | Put | 900.00K | $602.00K | — | ▾ |
XBISS SPDR S&P BIOTECH ETFS&P BIOTECH View history and evidence | Put | 500.00K | $465.00K | — | ▾ |
3 / 3 options · preview only
Exited positions 0
No exits reported this quarter.
Every number has a source.
CIK 1622627 · Period 2023-12-31
Data loaded 2026-09-23 · First reported 2024-02-14
Amendments and versions
{
"amendments_merged": null,
"prior_versions": null,
"cover_table_value": 121420416
}Take these holdings further.
This page includes 30 of 30 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.
- Download CSV
- Earlier quarters
- Advanced screening & filtering
- API & AI access
＋ New accounts get free API credits to explore data beyond ownership filings.
For AI agents & developers
The initial HTML of this page carries its exact data as script#portfolio-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. This page lists 30 of 30 current positions (options included); totals and weights use the complete filing.
Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.
MCP https://api.akkrudata.ai/mcp
get_institutional_portfolio
{"cik":"1622627","quarter":"2023Q4","page_size":100}
get_institutional_manager_history
{"cik":"1622627","page_size":100}Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.
- MCP endpoint
- https://api.akkrudata.ai/mcp
- API / MCP documentation
- /documents
- llms.txt
- /llms.txt
Sources, coverage & how to read this data
Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.